Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{180194,
        author = {Aniket Badule and Romit Bansod and Anjali Damahe},
        title = {Multidrug Resistant Tuberculosis: A Clinical Case Series},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {1},
        pages = {1004-1013},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=180194},
        abstract = {This case series evaluates ten patients diagnosed with multi-drug-resistant tuberculosis (MDR-TB) and treated at Central City Hospital from 2022 to 2024. It explores the diverse clinical presentations, diagnostic processes, treatment approaches, and outcomes to address the challenges in managing MDR-TB. The study examines factors contributing to drug resistance, treatment failures, and successful interventions, offering insights to improve clinical practices. Key findings emphasize the necessity of early diagnosis, comprehensive drug susceptibility testing, tailored treatment strategies, adherence support, and integrated care to enhance patient outcomes.},
        keywords = {MDR-TB, case series, drug-resistant, treatment outcome, clinical management, therapeutic challenges, anti-tubercular resistance},
        month = {June},
        }